No effect of human chorionic gonadotropin treatment due to threatened abortion in early pregnancy for birth outcomes

E. Czeizel, István Dudás, János Gidai, E. Puhó

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Human chorionic gonadotropin (HCG) is used parenterally for treatment of threatened abortions and repeated spontaneous abortion in pregnant women. No controlled epidemiological studies of preterm birth and low birthweight newborns in pregnant women with HCG treatment have been published while the results of animal investigations were controversial. The data of 97 pregnant women with HCG treatment in the second and third months of pregnancy due to threatened abortion and/or previous spontaneous abortion(s) was compared with the data of other 38,054 pregnant women in the population-based large data set of the Hungarian Case-Control Surveillance of Congenital Abnormalities. There was no difference in mean gestational age at delivery and birth weight, in addition the rate of preterm birth and low birthweight newborns. Parenteral HCG treatment in the early pregnancy due to threatened abortion did not associate with a higher risk for preterm births or low birthweight newborns. However, a higher occurrence of gestational diabetes was found in pregnant women with HCG treatment and there was a slight male excess among newborn infants (p=0.06).

Original languageEnglish
Pages (from-to)71-76
Number of pages6
JournalCentral European Journal of Medicine
Volume3
Issue number1
DOIs
Publication statusPublished - Mar 2008

Fingerprint

Threatened Abortion
Chorionic Gonadotropin
Pregnancy Outcome
Pregnant Women
Parturition
Premature Birth
Newborn Infant
Spontaneous Abortion
Therapeutics
Pregnancy
Gestational Diabetes
Induced Abortion
Birth Weight
Gestational Age
Epidemiologic Studies
Population

Keywords

  • Human chorionic gonadotropin
  • Low birthweight newborns
  • Pregnancy
  • Preterm birth
  • Threatened abortion

ASJC Scopus subject areas

  • Medicine(all)

Cite this

No effect of human chorionic gonadotropin treatment due to threatened abortion in early pregnancy for birth outcomes. / Czeizel, E.; Dudás, István; Gidai, János; Puhó, E.

In: Central European Journal of Medicine, Vol. 3, No. 1, 03.2008, p. 71-76.

Research output: Contribution to journalArticle

@article{d67937ac7af24c72acce04b5d24579b8,
title = "No effect of human chorionic gonadotropin treatment due to threatened abortion in early pregnancy for birth outcomes",
abstract = "Human chorionic gonadotropin (HCG) is used parenterally for treatment of threatened abortions and repeated spontaneous abortion in pregnant women. No controlled epidemiological studies of preterm birth and low birthweight newborns in pregnant women with HCG treatment have been published while the results of animal investigations were controversial. The data of 97 pregnant women with HCG treatment in the second and third months of pregnancy due to threatened abortion and/or previous spontaneous abortion(s) was compared with the data of other 38,054 pregnant women in the population-based large data set of the Hungarian Case-Control Surveillance of Congenital Abnormalities. There was no difference in mean gestational age at delivery and birth weight, in addition the rate of preterm birth and low birthweight newborns. Parenteral HCG treatment in the early pregnancy due to threatened abortion did not associate with a higher risk for preterm births or low birthweight newborns. However, a higher occurrence of gestational diabetes was found in pregnant women with HCG treatment and there was a slight male excess among newborn infants (p=0.06).",
keywords = "Human chorionic gonadotropin, Low birthweight newborns, Pregnancy, Preterm birth, Threatened abortion",
author = "E. Czeizel and Istv{\'a}n Dud{\'a}s and J{\'a}nos Gidai and E. Puh{\'o}",
year = "2008",
month = "3",
doi = "10.2478/s11536-007-0056-9",
language = "English",
volume = "3",
pages = "71--76",
journal = "Central European Journal of Medicine",
issn = "1895-1058",
publisher = "Springer Verlag",
number = "1",

}

TY - JOUR

T1 - No effect of human chorionic gonadotropin treatment due to threatened abortion in early pregnancy for birth outcomes

AU - Czeizel, E.

AU - Dudás, István

AU - Gidai, János

AU - Puhó, E.

PY - 2008/3

Y1 - 2008/3

N2 - Human chorionic gonadotropin (HCG) is used parenterally for treatment of threatened abortions and repeated spontaneous abortion in pregnant women. No controlled epidemiological studies of preterm birth and low birthweight newborns in pregnant women with HCG treatment have been published while the results of animal investigations were controversial. The data of 97 pregnant women with HCG treatment in the second and third months of pregnancy due to threatened abortion and/or previous spontaneous abortion(s) was compared with the data of other 38,054 pregnant women in the population-based large data set of the Hungarian Case-Control Surveillance of Congenital Abnormalities. There was no difference in mean gestational age at delivery and birth weight, in addition the rate of preterm birth and low birthweight newborns. Parenteral HCG treatment in the early pregnancy due to threatened abortion did not associate with a higher risk for preterm births or low birthweight newborns. However, a higher occurrence of gestational diabetes was found in pregnant women with HCG treatment and there was a slight male excess among newborn infants (p=0.06).

AB - Human chorionic gonadotropin (HCG) is used parenterally for treatment of threatened abortions and repeated spontaneous abortion in pregnant women. No controlled epidemiological studies of preterm birth and low birthweight newborns in pregnant women with HCG treatment have been published while the results of animal investigations were controversial. The data of 97 pregnant women with HCG treatment in the second and third months of pregnancy due to threatened abortion and/or previous spontaneous abortion(s) was compared with the data of other 38,054 pregnant women in the population-based large data set of the Hungarian Case-Control Surveillance of Congenital Abnormalities. There was no difference in mean gestational age at delivery and birth weight, in addition the rate of preterm birth and low birthweight newborns. Parenteral HCG treatment in the early pregnancy due to threatened abortion did not associate with a higher risk for preterm births or low birthweight newborns. However, a higher occurrence of gestational diabetes was found in pregnant women with HCG treatment and there was a slight male excess among newborn infants (p=0.06).

KW - Human chorionic gonadotropin

KW - Low birthweight newborns

KW - Pregnancy

KW - Preterm birth

KW - Threatened abortion

UR - http://www.scopus.com/inward/record.url?scp=38749134148&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=38749134148&partnerID=8YFLogxK

U2 - 10.2478/s11536-007-0056-9

DO - 10.2478/s11536-007-0056-9

M3 - Article

AN - SCOPUS:38749134148

VL - 3

SP - 71

EP - 76

JO - Central European Journal of Medicine

JF - Central European Journal of Medicine

SN - 1895-1058

IS - 1

ER -